Vanguard Portfolio Management reports 5.26% stake in Xylem (NYSE: XYL)
Rhea-AI Filing Summary
Xylem Inc. multiple Vanguard entities reported beneficial ownership of 12,800,726 shares of Common Stock, representing 5.26% of the class, on a Schedule 13G filing. The filing states Vanguard Portfolio Management LLC has sole dispositive power over 12,800,726 shares and sole voting power of 29,497 shares.
The filing explains these holdings reflect securities held across Vanguard funds and managed accounts for which Vanguard Portfolio Management LLC or affiliated business divisions exercise dispositive authority. The disclosure is signed by the Head of Global Fund Administration and dated 04/29/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard reports a passive 5.26% stake held via multiple managed vehicles.
Schedule 13G is used for passive investors; the filing here lists 12,800,726 shares and cites dispositive authority exercised by Vanguard Portfolio Management LLC and affiliates. The filing frames ownership as managed across funds and client accounts rather than a single proprietary holding.
Key dependencies include fund-level allocation and any future reclassification to a 13D if activist intentions arise; subsequent filings would change the public ownership picture.
Vanguard's disclosed voting and dispositive breakdown matters for shareholder vote tallies.
The filing reports 29,497 shares of sole voting power and 12,800,726 shares of sole dispositive power. That split is typical when investment advisers manage large beneficial positions while voting authority may reside in separate trustee or fund entities.
Watch for any future amendments that change voting direction or disclose coordinated action; current disclosure indicates routine passive ownership.